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more, the occurrence of slow-ﬂow, no-reﬂow, vessel dissection and branch vessel jail
are recorded.
Results: Baseline demographics and clinical characteristics, including age, sex,
smoking, ect, were similar between the two groups. There were not signiﬁcantly
different in baseline lesion characteristics. The maximum calcium arc and
calcium length ratio were (215.921.8) and (0.720.06) in RA group matched
with (226.521.6) and (0.780.05) in RC group, P>0.05. Before stent im-
plantation, the minimum lumen CSA was (2.520.07) mm2 in RA group and
(2.460.09) mm2 in RC group, without difference.The size of RA bur was
(1.44+0.02) mm and (1.46+0.01) mm in two groups, P>0.05. The cutting
balloon diameter used in RC group was (2.56+0.04) mm. The stent size were
(2.93+0.08) mm in RA group and (3.09+0.08) mm in RC group, P>0.05. After
RA and RA combined cutting balloon, there were 12 (35.3%) cases in RA
group and 26 (56.5%) cases in RC group could see the gaps, P¼0.189.
Although there was no statistical deference between the two groups, there was a
trend in RC group that more cases appear gaps after the adequate plaque
modiﬁcation.After stent implantation, the minimum stent area after stent im-
plantation and acute lumen gain of RC group were signiﬁcantly greater than
that of the RA group ((6.120.37) mm2 vs (5.420.24) mm2, P¼0.012;
(3.660.34) mm2 vs (2.900.24) mm2, P¼0.016). There were no statistical
differences in the occurrence of slow ﬂow, no-reﬂow, branch vessel jail and
vessel dissection between the two groups.
Conclusions: Rotational atherectomy combined with cutting balloon for treatment of
severely calciﬁed coronary lesions could signiﬁcantly increase the stent area, acute
lumen gain compared with rotational atherectomy alone, without increasing the PCI-
related complications.GW25-e1118
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Objectives: This IVUS study was designed to evaluate how calciﬁed parameters
(including calcium arc, calcium length ratio and calcium index) inﬂuence the results of
PCI.
Methods: From January 2012 to October 2012, 105 consecutive coronary artery
disease patients who underwent primary angioplasty with IVUS were analyzed in
our center. There were 34 no-calciﬁed lesions (no calcium of all lesion seg-
ments), 32 light-calciﬁed lesions (calcium length ratio<0.5 or calcium arc<180),
and 40 severe-calciﬁed lesions (calcium length ratio0.5 and calcium
arc180).IVUS was performed before percutaneous coronary intervention (PCI)
to measured lumen cross-sectional area (CSA), external elastic membrane (EEM),
Plaque and media CSA ¼ EEM CSA-lumen CSA. Lumen CSA of every 1 mm
of culprit lesion segment was measured and average lumen CSA was calculated.
For calcium, we measured maximum calcium arc, calcium length, and calcium
ratio (calcium length/lesion length). After stent implantation, IVUS was
rechecked to measure minimum stent CSA, minimum and maximum stent
diameter, and the reference lumen CSA. Stent symmetry ¼ minimum stent
diameter/maximum stent diameter. Stent expansion ¼ minimum stent CSA/
reference lumen CSA. Stent malapposition was deﬁned as insufﬁciently close
contact between some struts and the underlying wall. Stent asymmetry was
deﬁned as stent symmetry of at least one section<0.7. Stent underexpansion was
deﬁned as stent expansion rate <0.8.
Results: Severely calciﬁed lesions had smaller minimum lumen CSA, mean lumen
area, and minimum stent lumen CSA after PCI. And in severely calciﬁed lesions,
there was a higher occurrence of vessel dissection, vessel jail, stent malapposition,
stent asymmetry, and stent under-expansion. In all calciﬁed lesions, calcium arc has
a stronger inﬂuence for minimum lumen area (R2¼0.174, P¼0.000), minimum
stent area (R2¼0.256, P¼0.000), acute lumen gain (R2¼0.168, P¼0.000), and stent
expansion (R2¼0.103, P¼0.003) than calcium length ratio (min lumen area:
R2¼0.005, P¼0.445; min stent area: R2¼0.085, P¼0.007; acute lumen gain:
R2¼0.074, P¼0.012; stent expansion: R2¼0.007, P¼0.222) and calcium index (min
lumen area: R2¼0.108, P¼0.002; min stent area: R2¼0.237, P¼0.000; acute lumen
gain: R2¼0.167, P¼0.000; stent expansion: R2¼0.086, P¼0.007). Calcium length
ratio has a stronger inﬂuence for vessel dissection (OR¼7.528, 95%CI 1.395-
40.643, P¼0.019) than calcium arc (OR¼1.005, 95%CI 1.001-1.010, P¼0.026) and
calcium index (OR¼5.647, 95%CI 1.195-26.678, P¼0.029). Calcium index
(R2¼0.261, P¼0.000) has stronger inﬂuence for mean lumen area and incomplete
stent apposition (OR¼19.658, 95%CI 3.233-119.509, P¼0.001) than calcium arc
(mean lumen area R2¼0.158, P¼0.000; incomplete stent apposition OR¼1.011,
95%CI 1.004-1.018, P¼0.001) and calcium length ratio (mean lumen area
R2¼0.236, P¼0.000; incomplete stent apposition OR¼12.945, 95%CI 1.766-
94.913, P¼0.012). Vessel loss seemed to have no liner relationship with calcium
parameters.
Conclusions: For calciﬁed lesions, we should consider both calcium arc and length.
The minimum lumen area, minimum stent area, acute lumen gain, and stent expansion
are mainly affected by calcium arc. Stent symmetry and the occurrence of vessel
dissection are mainly affected by calcium length ratio. Mean lumen area and stent
malapposition are mainly affected by calcium index.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e2152
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Objectives: The aim of present analysis was to compare ischemic postconditioning
(IPC) with remote ischemic conditioning (RIPC) in primary percutaneous coronary
intervention (pPCI), a network meta-analysis was performed using a Bayesian
approach.
Methods: Published randomized controlled trials included either IPC or RIPC in
patients with ST-elevation acute myocardial infarction (STEMI) during pPCI were
identiﬁed though the PubMed, EMBASE, and Cochrane central Register of Controlled
Trials database, and the ClinicalTrials.gov database up to December 2013. Outcomes
of interest were enzymatic infarct size, infarct size assessed by cardiac magnetic
resonance (CMR), complete ST-segment resolution (cSTR) and cardiac events during
follow-up. A Bayesian network meta-analysis was performed using WinBUGS 1.43
and R 3.02.
Results: Sixteen studies including results of 1773 IPC and RIPC patients were
identiﬁed. Pooled results showed no signiﬁcant decrease in enzymatic infarct size
among patients treated with IPC compared to RIPC (standardized mean difference
[SMD], -0.17; 95% Conﬁdence Interval [CI], -6.62 to 6.57). Compared with IPC,
RIPC tended to reduce infarct size evaluated by CMR. (Mean difference [MD],
2.77%; 95%CI,-6.40% to 12.17%).There was a trend toward more cSTR in IPC pa-
tients than in RIPC subjects (odds ratio [OR], 1.54; 95%CI, 0.42 to 4.18). There was
no signiﬁcant difference in mortality (OR, 0.79; 95%CI, 0.02 to 3.53) or reinfarction
(OR, 1.05; 95%CI, 0.001 to 4.42) during 1 month to 3.4 years among patients treated
with IPC compared to RIPC.
Conclusions: In STEMI patients undergoing pPCI, available evidence from this
network meta-analysis suggests the non-superiority of IPC vs RIPC on infarct size,
cSTR and incidence of mortality or reinfarction. Further head-to-head in-
vestigations are necessary to evaluate the effect of two adjunctive therapies during
pPCI.GW25-e3237
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Objectives: The objective of this study is to evaluate the clinical value of the index of
microcirculatory resistance (IMR) for assessing short period prognosis of patients with
sub-acute myocardial infarction undergoing elective percutaneous coronary inter-
vention (PCI).
Methods: In 54 stable patients with ST-segment elevation myocardial infarction after
11.13.3days from symptom onset, IMR was measured after successful PCI. 28
(52%) patients had normal IMR value (IMR <32U, 19.87.3U) and 26 (48%) pa-
tients with IMR>32U (60.721.9U). Transthoracic echocardiography, 6 minutes
walking test and major adverse cardiac events (MACE) were followed up at
39.37.23 days.
Results: IMR correlated signiﬁcantly with 6 minutes walking distances (r ¼-0.504,
P<0.001), but not signiﬁcantly with left ventricular ejection fraction (LVEF)
(r ¼-0.074, P ¼0.595). There were no people reoccurred myocardial infarction or stent
re-implantation. The re-admission rate of patients with normal and abnormal IMR was
2 (7%) and 6 (23%), respectively (P¼0.135). Patients with normal IMR had less
recurrence of angina pectoris compared with patients with higher IMR (4[14%] vs. 12
[46%], P¼0.016), and IMR demonstrated signiﬁcant correlation with recurrence of
angina (r ¼0.352, P ¼0.009).
Conclusions: IMR can be regarded as a predictor of the quality of life of patients
with sub-acute myocardial infarction undergoing elective PCI in short term. But it is
not reliable in assessing the left ventricular function recovery and MACE in
short term.GW25-e4113
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Objectives: Coronary intervention using transradial approach is common worldwide.
It is normally necessary to use one diagnostic catheter and guiding catheter in primary
percutaneous coronary intervention (PCI) for ST elevation myocardial infarction
(STEMI). It is unknown whether using a single guiding catheter for both nonculpritardiovascular Disease Clinical Research C139
